Resistance Mechanisms to Targeted Therapies in ROS1(+) and ALK(+) Non-small Cell Lung Cancer.
ROS1(+)和ALK(+)非小细胞肺癌对靶向治疗的耐药机制
期刊:Clinical Cancer Research
影响因子:10.2
doi:10.1158/1078-0432.CCR-17-2452
McCoach Caroline E, Le Anh T, Gowan Katherine, Jones Kenneth, Schubert Laura, Doak Andrea, Estrada-Bernal Adriana, Davies Kurtis D, Merrick Daniel T, Bunn Paul A Jr, Purcell W Tom, Dziadziuszko Rafal, Varella-Garcia Marileila, Aisner Dara L, Camidge D Ross, Doebele Robert C
